A review of six bioactive compounds from preclinical studies as potential breast cancer inhibitors
Crossref DOI link: https://doi.org/10.1007/s11033-025-10300-0
Published Online: 2025-02-05
Published Print: 2025-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rampogu, Shailima
Al-antari, Mugahed A.
Oh, Tae Hwan
Shaik, Baji
Text and Data Mining valid from 2025-02-05
Version of Record valid from 2025-02-05
Article History
Received: 19 June 2024
Accepted: 23 January 2025
First Online: 5 February 2025
Declarations
:
: The authors declare no competing interests.